Key facts
- My Fit’s last known valuation is $2.8M (Dec 2024).
- It has raised $5.5M; the latest was Early Stage VC ($490K) in Dec 2024.
- Notable investors include AgVenture Lab, Aoyama Startup Acceleration Center (ASAC), Apt Women, G-STARTUP, MRSO — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for My Fit
- ·The full record, as it builds
Funding rounds
No funding rounds for My Fit are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About My Fit
Operator of a personalized health care platform intended to provide individualized solutions online for menopausal women. The company's platform offers medical treatment by doctors and prescription drugs such as hormone replacement therapy and Chinese herbal medicine, as well as tailored medication to each individual such as supplements, counseling, and dietary advice, enabling people to live a healthy life both physically and mentally by providing healthcare that fits each individual.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2021
- Website
- my-fit.co/
- Ownership
- Privately Held (backing)
My Fit doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in My Fit shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on My Fit in its N-PORT filings yet. We sweep new filings monthly.